Point-Counterpoint: Genotype-Guided Warfarin Therapy
Lu, W.Jessie.; Miller, N.J.
South Dakota medicine the journal of the South Dakota State Medical Association 70(2): 54-56
2017
ISSN/ISBN: 0038-3317 PMID: 28810086 Document Number: 691726
Document emailed within 1 workday
Related Documents
Rodríguez-Vélez, R.án.; Ortiz-Rivera, O.J.; Bower, B.; Gorowski, K.; Windemuth, A.; Villagra, D.; Kocherla, M.; Seip, R.L.; D'Agostino, D.; Vergara, C.; Ruaño, G.; Duconge, J. 2010: Exposure to non-therapeutic INR in a high risk cardiovascular patient: potential hazard reduction with genotype-guided warfarin (Coumadin) dosing Puerto Rico Health Sciences Journal 29(4): 402-408Snow, J.S. 1980: Medical devices: point-counterpoint Emergency Medical Services 9(1): 77-78; 80
Parks, W.P. 1995: Point/counterpoint: I. HIV-1 screening of pregnant women Obstetrical and Gynecological Survey 50(1): 1-2
Flamm, B.L. 1998: Point/counterpoint: I. Vaginal birth after cesarean: where have we been and where are we going? Obstetrical and Gynecological Survey 53(11): 661-662
Friedman, M.A. 1990: Point/Counterpoint. NCI Clinical Alert policy. If not now, when? Journal of the National Cancer Institute 82(2): 106 108
Balkany, T. 1989: Controversies in pediatric otology: point/counterpoint--perilymph fistula American Journal of Otology 10(6): 493
Henderson, I.C. 1990: Point/Counterpoint. NCI Clinical Alert policy. Shouldn't we see the white flag before we cry victory? Journal of the National Cancer Institute 82(2): 103 105 107 Passim
Carroll, W.E.; Jackson, R.D. 1999: Modified anticoagulant therapy factor and international normalized ratio in patients in an unstable coagulation state with respect to warfarin therapy Research Communications in Molecular Pathology and Pharmacology 105(3): 262-270
Scott, E.A.; Sandler, G.A.; Byars, T.D. 1978: Warfarin: effects of intravenous loading doses and vitamin K on warfarin anticoagulation in the pony American Journal of Veterinary Research 39(12): 1888-1891
de Serres, F.J.; Overton, L.K.; Sadler, B.M. 1992: X-ray-induced specific-locus mutations in the ad-3 region of two-component heterokaryons of Neurospora crassa. XI. Heterozygous effects of gene/point mutations of genotype ad-3A or ad-3B Mutation Research 269(1): 149-169
Koefoed, B.G.; Feddersen, C.; Gulløv, A.L.; Petersen, P. 1997: Effect of fixed minidose warfarin, conventional dose warfarin and aspirin on INR and prothrombin fragment 1 + 2 in patients with atrial fibrillation Thrombosis and Haemostasis 77(5): 845-848
Kulkarni, V.; Bhave, A.; Munshi, R.K.; Bhalerao, S.; Bhattad, D.; Khude, S.; Upase, D. 2013: Warfarin therapy--why one dose does not fit all! Journal of the Association of Physicians of India 61(8): 571-573
Liebeschuetz, S.; Baddeley, H.; Thomas, D.J. 1994: Haematomyelia following warfarin therapy British Journal of Clinical Practice 48(2): 105-106
Asano, M.; Taniwaki, H.; Tsuji, D.; Sato, Y.; Shimizu, T. 2005: Cytochrome P450 2C19 genotype -based second line therapy with amoxicillin and lansoprazole after failure of initial helicobacter pylori eradication therapy Nihon Rinsho. Japanese Journal of Clinical Medicine 63(Suppl 12): 450-453
Elliot, M.S.; Immelman, E.J.; Jeffery, P.; Benatar, S.R.; Funston, M.R.; Smith, J.A.; Jacobs, P.; Shepstone, B.J.; Ferguson, A.D.; Louw, J.H. 1978: Skin necrosis after warfarin therapy South African Medical Journal 54(15): 609-610
Bradlow, B.A. 1983: Warfarin therapy--a practical guide South African Medical Journal 64(9): 317-319
Kostka, R.; Havlůj, L.; Jirava, D.; Novák, L.; Vach, B.; Weiss, J. 2010: Hemorrhagic complications of warfarin therapy Rozhledy V Chirurgii: Mesicnik Ceskoslovenske Chirurgicke Spolecnosti 89(2): 124-129
Carter, B.L. 1991: Therapy of acute thromboembolism with heparin and warfarin Clinical Pharmacy 10(7): 503-518
Ebell, M.H. 1999: Determining the risk of bleeding in warfarin therapy Journal of Family Practice 48(6): 413
Brooks, B.J.; Mocklin, K.E. 1981: Retropharyngeal hematoma as a complication of warfarin therapy Journal of the Louisiana State Medical Society: Official Organ of the Louisiana State Medical Society 133(10): 156-157